Literature DB >> 20724909

Recurrent Lower Extremity Pseudocellulitis.

Alex Korniyenko1, James Lozada, Aditi Ranade, Gagangeet Sandhu.   

Abstract

The term "Pseudocellulitis" can be used to describe an uncomplicated nonnecrotizing inflammation of the dermis and hypodermis from a noninfectious etiology. Chemotherapeutic agents have been associated with a variety of cutaneous reactions, including radiation recall dermatitis, hypersensitivity reactions, and erysipeloid reactions. Gemcitabine (2,2-difluorodeoxycytidine) is currently being used for treatment of a variety of solid malignancies, including carcinoma of the lung. The dermatitis involved with gemcitabine is typically a radiation recall reaction whereby an inflammatory reaction occurs in the area previously treated with radiotherapy. We describe here a case of Gemcitabine-induced pseudocellulitis that was unrelated to radiation exposure and manifested in an area of lymphedema. The pseudocellulitis in such cases could be related to the drug's pharmacokinetics and may last until the drug is displaced from the subcutaneous tissue of the affected area. Antibiotics have no role in the treatment, and diphenhydramine with nonsteroidal anti-inflammatories may be used for symptomatic management.

Year:  2010        PMID: 20724909     DOI: 10.1097/MJT.0b013e3181eea6a4

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  1 in total

1.  Gemcitabine-associated acute lipodermatosclerosislike eruption: An underrecognized phenomenon.

Authors:  Amit Mittal; Jonathan S Leventhal
Journal:  JAAD Case Rep       Date:  2017-04-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.